Generic Name
TemozolomidePacks Price
- Cap 100 mg(066113): 5: 26350.00: 31000.00
- Cap 20 mg(066112): 5: 5270.00: 6200.00
- Cap 250 mg(066114): 5: 65878.00: 77504.00
Temoside
Therapeutic Group
Anti-neoplasticsIndication Dosage
Temozolomide is a medication primarily used in the treatment of certain types of brain tumors, specifically glioblastoma multiforme and anaplastic astrocytoma. It is prescribed to patients as part of a comprehensive treatment plan, including surgery and radiation therapy, to slow down or inhibit the growth of cancer cells within the brain. Temozolomide works by interfering with the DNA replication process in rapidly dividing cancer cells, ultimately impeding their ability to proliferate.
Newly Diagnosed Glioblastoma Multiforme In Adults (in Combination With Radiotherapy) And Subsequently As Monotherapy, Second-line Treatment Of Malignant Glioma In Adults:
- Adults: 150-200 Mg/m2/day For 5 Days, Repeat Every 28 Days (consult Product Literature)
Content
- Cap 5mg /20mg /100mg /140mg /180mg /250mg: Temozolomide 5mg /20mg /100mg /140mg /180mg /250mg.
Pregnancy
Positive Evidence Of Risk: Avoid
Stability
- Alkylating Agent
Contra Indications
- None Known
Precautions
- None Known
Lactation
- Contraindicated. Discontinue Breast-feeding
Side Effects
- Alopecia
- Bone-marrow Suppression
- Hyperuricaemia
- Nausea
- Oral Mucositis
- Peripheral Oedema Thromboembolism
- Tumourlysis Syndrome
- Vomiting
Available Brands
Author
Shahid Arif